Ranbaxy
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & Aspirations Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.
Pharmaceuticals
> 10,000
Nawanshahr, India
About

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over
125 countries.

In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing.

Vision & Aspirations

Ranbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012.

Financials

Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.

Site Traffic
  • 3805207 Global Rank
  • 189998
    India
Traffic Sources
  • Direct
    85.88%
  • Referrals
    10.86%
  • Search
    3.26%
  • Display
    0.00%
  • Mail
    0.00%
  • Social
    0.00%
Powered by
Alexa Traffic Data
Global Rank 1,110,790
266,689
India Rank 100,634
393,955
India Page Views 99.3%
18.1%
Top Countries
Top Search Keywords
  • Formats
  • College and Educational
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 500 Downloads
  • 0 SDKs
  • 4.33 Avg. Rating
  • 4 Total reviews
  • App Url: https://play.google.com/store/apps/details?id=com.conference.ranbaxy
  • App Support: http://www.ranbaxy.com
  • Genre: medical
  • Bundle ID: com.conference.ranbaxy
  • App Size: 1.4 M
  • Version: 2
  • Release Date: January 2nd, 2013
  • Update Date: February 22nd, 2013

Description:

Ranbaxy Super Specialties presents for the 1st time in India - an Oncology Conference Planner android application. This application contains details of plenty of oncology conferences scheduled in 2013. It includes details like conference name, date, venue and website.You can also add your favourite CME/conference if it is missing from the list. A checklist is also provided which helps you to plan your conference in a better way (Registration, Stay and Travel). Notifications regarding your registration, stay and travel for the selected conferences (as favourites) will appear at regular intervals so that you plan everything well in advance.
So, what are you waiting for ? Go grab it !! Install it now.
Regards,
Ranbaxy Super Specialties Team

SS/XTZ/AS/PG/LBL/02-73-311212

They are headquartered at Nawanshahr, India, and have 5 advertising & marketing contacts listed on Kochava. Ranbaxy works with Advertising technology companies such as DoubleClick.Net.